Accord Pharmaceuticals appoints NIBL Ace Capital as share underwriter for its upcoming IPO; to float 7.06 lakh units’ ordinary shares to public soon
Accord Pharmaceuticals has appointed NIBL Ace Capital as a share underwriter for its upcoming IPO of 7.06 lakhs ordinary shares.
The agreement regarding the same was signed between MD of the Pharma company Mr. Bishal Pandit and Deputy MD of the merchant banker Mr. Sachindra Dhungana amid a program, as per the media statement.
